(ETHZ)
NASDAQ: ETHZ
· Real-Time Price · USD
7.21
-0.20 (-2.70%)
At close: Aug 19, 2025, 11:59 AM
Company Description
ETHZilla operates in digital asset management, gaming, and entertainment.
The Company is developing an Ether (ETH) accumulation vehicle to serve as a benchmark for on-chain treasury management among public companies, supported by Electric Capital and a DeFi Council of industry experts.
Its strategy targets yield generation beyond traditional ETH staking while advancing gaming initiatives and pursuing monetization of legacy biotechnology assets from its origins as a biotech company.
| Country | United States |
| IPO Date | Jun 27, 2017 |
| Industry | Asset Management - Cryptocurrency |
| Sector | Financial Services |
| Employees | 4 |
| CEO | Lloyd Blair Jordan |
Contact Details
Address: Building 4 Palo Alto, California United States | |
| Website | https://180lifesciences.com |
Stock Details
| Ticker Symbol | ETHZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001690080 |
| CUSIP Number | 68236V104 |
| ISIN Number | US68236V3024 |
| Employer ID | 81-3832378 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Lloyd Blair Jordan L.L.B., M.B.A. | Chief Executive Officer & Director |
| Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder & Director |
| Eric R. Van Lent | CAO, Principal Accounting & Financial Officer |
| Prof. Jagdeep Nanchahal M.D., Ph.D. | Co-Founder & Chairman of Clinical Advisory Board |
| Sir Marc Feldman Ph.D. | Co-Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 18, 2025 | 8-K | Current Report |
| Aug 18, 2025 | 8-K/A | [Amend] Current Report |
| Aug 14, 2025 | 8-K | Current Report |
| Aug 14, 2025 | 424B5 | Filing |
| Aug 13, 2025 | 8-K | Current Report |
| Aug 12, 2025 | 4 | Filing |
| Aug 12, 2025 | 3 | Filing |
| Aug 12, 2025 | SCHEDULE 13G | Filing |
| Aug 12, 2025 | 8-K | Current Report |
| Aug 11, 2025 | 4 | Filing |